ASND ▲ +0.4% - Ascendis Pharma A/S
$ASND - Ascendis and BioMarin Enter Binding Term Sheet for a Global Settlement and License Agreement Related to YUVIWEL® (Navepegritide)
Ascendis Pharma rose 0.4% following news that the company and BioMarin have entered into a binding term sheet for a global settlement and license agreement related to YUVIWEL® (navepegritide). The settlement appears to resolve a dispute between the two companies while establishing a licensing arrangement for the growth hormone treatment, which likely reduces legal uncertainty for Ascendis.
31-AUG-2026 07:00 AM ET
Share this post
More filings for $ASND
ASND - Ascendis Pharma A/S - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 16, 2026ASND ▲ +2.2% - Ascendis Pharma A/SNov 12, 2026ASND ▲ +2.2% - Ascendis Pharma A/SNov 12, 2026ASND ▼ -1.3% - Ascendis Pharma A/SNov 10, 2026ASND ▲ +0.0% - Ascendis Pharma A/SNov 6, 2026ASND ▼ -1.8% - Ascendis Pharma A/SNov 5, 2026
View full $ASND filing history →💬 Comments
Loading comments…
Leave a comment
